Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.16
-0.45 (-3.57%)
At close: Sep 3, 2026, 4:00 PM EDT
12.21
+0.05 (0.41%)
Pre-market: Sep 4, 2026, 7:06 AM EDT
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $166.64 million as of September 3, 2026. Its market cap has increased by 1,813.58% in one year.
Market Cap
166.64M
Enterprise Value
120.37M
1-Year Change
1,813.58%
Ranking
Category
Stock Price
$12.16
ChartMarket Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has increased from $141.44M to $166.64M, an increase of 17.81%. That is a compound annual growth rate of 0.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 166.64M | 113.35% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 159.93M |
| Humacyte | 159.34M |
| LENZ Therapeutics | 157.73M |
| Outlook Therapeutics | 153.37M |
| Tenaya Therapeutics | 152.92M |
| NRx Pharmaceuticals | 150.12M |
| Indaptus Therapeutics | 149.90M |
| OnKure Therapeutics | 147.81M |